Hoth Therapeutics Inc. (NASDAQ: HOTH)
$0.90
-0.0300 ( -3.23% ) 41.3K
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.
Market Data
Open
$0.90
Previous close
$0.93
Volume
41.3K
Market cap
$5.02M
Day range
$0.90 - $0.99
52 week range
$0.83 - $3.37
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
def | Proxies and info statements | 6 | Jun 18, 2024 |
ars | Annual reports | 1 | Jun 18, 2024 |
8-k | 8K-related | 14 | Jun 17, 2024 |
10-q | Quarterly Reports | 62 | May 14, 2024 |
8-k | 8K-related | 16 | Mar 28, 2024 |
10-k | Annual reports | 76 | Mar 28, 2024 |
8-k | 8K-related | 12 | Jan 09, 2024 |
4 | Insider transactions | 1 | Jan 08, 2024 |
4 | Insider transactions | 1 | Jan 08, 2024 |
4 | Insider transactions | 1 | Jan 08, 2024 |